
VolitionRx Limited
VNRXNYSEAMERICANHealthcareMedical Devices
As of Oct 26, 2026 close
- Market cap
- $1.64M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.17$6.30
- Volume (live)
- -
- Avg. volume (3M)
- 2.44M
VolitionRx (VNRX) Stock Price & Financial Analysis
VolitionRx Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.16 - $0.19 |
|---|---|
| 52-Week High | $6.30 |
| 52-Week Low | $0.17 |
| Open | $0.19 |
| Volume (last close) | 3.98M |
| Average Volume (3M) | 2.44M |
| Revenue (TTM) | 2.28M |
|---|---|
| Net Income (TTM) | -26.53M |
| Free Cash Flow (TTM) | -21.46M |
| EPS (TTM) | −$3.87 |
| Profit Margin | -1164.83% |
| Operating Margin | -834.72% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.64M |
|---|---|
| Shares Outstanding | 9.15M |
| Price to Sales (P/S) | 0.72 |
| Price to Book (P/B) | -0.05 |
| EV/EBITDA | -0.48 |
| 50-Day MA | $0.33 |
|---|---|
| 200-Day MA | $1.93 |
| 1-Year Change | −60.21% |
Source: Market prices and company fundamentals. Data as of Oct 27, 2026. Data sources and methodology
VolitionRx at a Glance
As of the Oct 27, 2026 close, VolitionRx (VNRX) has a market capitalization of $1.64M. The stock trades at 0.7× sales. Over the trailing twelve months it lost $26.53M on revenue of $2.28M and burned $21.46M of free cash flow. Revenue grew 54.7% year over year.
As of its latest reported balance sheet, it holds $2.79M in cash and securities against $10.71M of debt, a net debt position of $7.92M.
VolitionRx does not currently pay a dividend.
The share price is down 60.2% over the past year. At $0.18 (the Oct 27, 2026 close) it sits near the bottom of its 52-week range of $0.17 to $6.30, below its 200-day moving average of $1.93.
Frequently Asked Questions About VolitionRx
What is the current stock price for VNRX?
As of the Oct 27, 2026 close, VNRX stock trades at $0.18. The 52-week range is $0.17–$6.30, with a day range of $0.16–$0.19.
What is the P/E ratio for VNRX?
The P/E ratio (Price-to-Earnings) for VNRX is shown in the Key Statistics section. This valuation metric helps compare VolitionRx Limited to industry peers.
Does VNRX pay dividends?
VolitionRx does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VNRX?
Analyst ratings and recommendations for VNRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VNRX?
As of the Oct 27, 2026 close, VolitionRx's market capitalization is $1.7M, classifying it as a micro-cap company. VolitionRx operates in the Healthcare sector within the Medical Devices industry.